Mounjaro before and after: a photo shows an endpoint, never the average. In SURMOUNT-1, the largest trial of tirzepatide, participants lost on average 15.0% to 20.9% of their body weight over 72 weeks depending on the dose, versus 3.1% on placebo (NEJM, 2022). Photos keep the most striking differences, not the most common path.
Mounjaro before and after: what do these photos really represent?
A Mounjaro before and after photo freezes two moments and erases everything in between: how long it took, which dose was reached, the weeks when nothing moved, and any stops along the way. To see where an image sits in reality, compare it with the average weight loss in Mounjaro clinical trials, which gives the order of magnitude across a large group rather than a hand-picked case.
Ask three questions of any before and after: how much time separates the two pictures, at what dose, and how many people in the same situation were not photographed. A published image has almost always been chosen because it impresses. That is fine for social media, but it makes it a poor yardstick for your own expectations. Note also that tirzepatide is sold as Mounjaro in many countries and as Zepbound for weight management in the United States, so the same trial results sit behind both names.
How much weight loss sits behind a Mounjaro before and after?
In the SURMOUNT-1 trial, average weight loss with tirzepatide at 72 weeks was 15.0% with 5 mg, 19.5% with 10 mg and 20.9% with 15 mg, versus 3.1% with placebo. The trial enrolled 2,539 adults with obesity, or overweight plus a weight-related complication, without diabetes, with an average starting weight of 104.8 kg (about 231 lb).
| Group (72 weeks) | Average loss | Loss of 5% or more | Loss of 20% or more |
|---|---|---|---|
| Tirzepatide 5 mg | −15.0% | 85% | not stated in the abstract |
| Tirzepatide 10 mg | −19.5% | 89% | 50% |
| Tirzepatide 15 mg | −20.9% | 91% | 57% |
| Placebo | −3.1% | 35% | 3% |
For a starting weight of 220 lb (100 kg), these averages correspond to roughly 33 to 46 lb (15 to 21 kg): simple arithmetic, not an individual forecast. The placebo row is a reminder that some visible change also comes from the diet support every participant received.
Why are before and after photos misleading?
Before and after photos are misleading because nearly everything that changes how a body looks can be changed without any fat moving: light, angle, posture, lens, time of day and which pictures get picked. As early as 2002, the US Federal Trade Commission (FTC) flagged deceptive before and after photos in weight-loss advertising.
- Lighting. Harsh overhead light carves shadows; flat front light smooths everything. Two photos ten minutes apart can look like two different bodies.
- Posture. Relaxed stomach in the “before”, arched back and open shoulders in the “after”: the difference shows with no weight lost.
- Angle and distance. A close lens distorts; a slightly low camera elongates. Tiny shifts matter.
- Timing. The “before” is often taken at a low point (bloated, tight clothing), the “after” on a good day.
- Editing. Filters, smoothing and cropping are common, even with no intent to deceive.
- Selection. The most dramatic successes get shared. People with smaller changes, or who stopped, rarely post.
The FTC release on weight-loss advertising covered an old sample and products unrelated to Mounjaro, so it says nothing about tirzepatide; it only shows the technique has been known for a long time.
What does a Mounjaro before and after at 1 month show?
A Mounjaro before and after at one month rarely shows a visible transformation: the dose is still low and weight loss has not found its pace. In SURMOUNT-1, the dose was raised gradually over a 20-week escalation period before reaching the maintenance dose.
That explains two effects photos blend together: the water and gut-content swings of the first weeks, which can move the scale without the body changing, and the first real changes, which only appear with time. For a reference point, our first month on Mounjaro, week by week describes what people observe, without promising a number. A one-month photo that shows “nothing” is not a failure; it is simply early.
Why don’t two people on Mounjaro get the same “after”?
Two people on Mounjaro don’t get the same “after” because results spread around the average: in SURMOUNT-1, 57% of participants on 15 mg lost 20% or more of their weight, which means 43% did not reach that mark. Outcomes depend on starting weight, tolerated dose, duration and consistency.
The same trial reports that 4.3%, 7.1% and 6.2% of participants stopped treatment because of adverse events, depending on dose (5, 10, 15 mg), versus 2.6% on placebo. The published averages still include those people. In other words, the averages do not describe “those who succeed”; they describe the whole group.
The scale also doesn’t say what you lose. A photo can’t tell fat from muscle, and it doesn’t show skin that loosens; those topics have their own guides on muscle loss on GLP-1 treatment and loose skin after weight loss.
How can you take honest progress photos of your own?
To take honest progress photos on Mounjaro, recreate the exact same conditions each time: same room, same light, same distance, same time of day, same clothing and the same relaxed pose. The goal isn’t to flatter; it’s to compare two images that differ only by what has genuinely changed.
- Same place, same time. Morning, before eating, limits bloating variation.
- Same pose, uncorrected. Standing, arms at your sides, front then side, without sucking in or arching.
- Same distance. Rest the phone on a fixed-height support rather than holding it at arm’s length.
- Same rhythm. Every four weeks is plenty: more often, you will mostly see noise.
- No filters. These photos are for you, not for an audience.
In the MounjaGO app, the “Progress photos” section saves each photo with its date and an optional note, and offers a “Gallery” and a “Comparison” between two shots. Log your injections and weigh-ins there too, so what you see in a picture can be linked to what you actually did. To set your starting point, you can also check your BMI and weight-loss projection.
What should you measure besides the scale and photos?
Besides the scale and photos, waist circumference is the simplest and most useful extra measurement to follow on Mounjaro. To take it, find the bottom of your ribs and the top of your hips, then place the tape halfway between them, as the British Heart Foundation describes.
A common benchmark is waist-to-height ratio: the NHS advises keeping your waist to less than half your height. The WHO devoted an expert report to these measurements and their link with disease risk. Your waist can shrink while the scale stalls, which is why tracking several indicators, as explained in why weight tracking is not enough, prevents hasty conclusions. Note your energy, sleep and how your clothes fit too.
What if comparing your photos makes you feel bad?
If comparing your photos on Mounjaro makes you uncomfortable, that is a common reaction and nothing obliges you to take them: scale, waist measurement or how you feel can be enough. Looking at yourself after a body change can be disorienting, even when the result is what you hoped for.
Our article on body image on GLP-1 treatment looks at the gap between the mirror and the scale. If the discomfort lingers or affects how you relate to food, talk to your doctor or another health professional: it is a health question in its own right.
Limits of these data
The SURMOUNT-1 figures are 72-week averages in adults without diabetes, followed with diet support, in a trial funded by Eli Lilly, the maker of tirzepatide. They say nothing about your individual result, and even less about what a photo of you would show on a given date. Here is what these data do not cover.
- We give no one-month figure: the trial abstract does not report it and we have no verified open source.
- We give no waist-circumference change on Mounjaro either, for lack of a verified source.
- The photographic biases described here are well-known practices; we do not quantify their effect.
- The FTC release dates from 2002 and concerns other products.
Frequently asked questions
What results should you expect from a Mounjaro before and after?
SURMOUNT-1 averages range from −15.0% to −20.9% of body weight at 72 weeks depending on dose, but they are averages for a group followed with support. Your result may be lower or higher, and it does not follow a steady line.
Can you trust before and after photos on social media?
Rarely. Light, posture, angle, editing and selection of the best cases can change the impression without any real change. A single photo says nothing about dose, duration, or how many others did not get that result.
How often should you take progress photos on Mounjaro?
Every four weeks is enough, in the same conditions: same place, same time, same pose. More often and you will mostly compare water and bloating changes.
Is waist circumference more reliable than the scale?
It gives different information, not necessarily more reliable: it can fall while weight stalls. Measured halfway between ribs and hips, it can be compared with height; the NHS advises a waist under half your height.
Should you show your photos to your doctor?
If you wish: they can complement your weigh-ins and measurements at an appointment. Any decision on dose or on continuing treatment is made with your doctor or pharmacist.
Sources
- Jastreboff AM, Aronne LJ, Ahmad NN et al. “Tirzepatide Once Weekly for the Treatment of Obesity” (SURMOUNT-1). New England Journal of Medicine, 2022. PMID 35658024 · DOI 10.1056/NEJMoa2206038, accessed .
- Federal Trade Commission, “FTC Releases Report on Weight-Loss Advertising”, September 17, 2002. ftc.gov, accessed .
- British Heart Foundation, Why your waist size matters. bhf.org.uk, accessed .
- NHS, Calculate your waist-to-height ratio. nhs.uk, accessed .
- World Health Organization, Waist circumference and waist-hip ratio: report of a WHO expert consultation, 2011. who.int, accessed .
Medical disclaimer. This article is for information only and does not replace medical advice. The figures cited are clinical-trial averages and do not predict your individual result; no outcome is promised. Any decision to start, change or stop a treatment should be made with a doctor or pharmacist. Last checked October 5, 2026.